chr1-220182842-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_012414.4(RAB3GAP2):​c.2088A>G​(p.Thr696Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0066 in 1,613,554 control chromosomes in the GnomAD database, including 552 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 286 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 266 hom. )

Consequence

RAB3GAP2
NM_012414.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.613

Publications

3 publications found
Variant links:
Genes affected
RAB3GAP2 (HGNC:17168): (RAB3 GTPase activating non-catalytic protein subunit 2) The protein encoded by this gene belongs to the RAB3 protein family, members of which are involved in regulated exocytosis of neurotransmitters and hormones. This protein forms the Rab3 GTPase-activating complex with RAB3GAP1, where it constitutes the regulatory subunit, whereas the latter functions as the catalytic subunit. This gene has the highest level of expression in the brain, consistent with it having a key role in neurodevelopment. Mutations in this gene are associated with Martsolf syndrome.[provided by RefSeq, Oct 2009]
RAB3GAP2 Gene-Disease associations (from GenCC):
  • Martsolf syndrome 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • RAB18 deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Warburg micro syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Warburg micro syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive spastic paraplegia type 69
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cataract-intellectual disability-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-220182842-T-C is Benign according to our data. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-220182842-T-C is described in CliVar as Benign. Clinvar id is 130077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.613 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAB3GAP2NM_012414.4 linkc.2088A>G p.Thr696Thr synonymous_variant Exon 20 of 35 ENST00000358951.7 NP_036546.2 Q9H2M9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAB3GAP2ENST00000358951.7 linkc.2088A>G p.Thr696Thr synonymous_variant Exon 20 of 35 1 NM_012414.4 ENSP00000351832.2 Q9H2M9-1

Frequencies

GnomAD3 genomes
AF:
0.0337
AC:
5135
AN:
152200
Hom.:
287
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0131
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.00941
AC:
2363
AN:
251194
AF XY:
0.00729
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.00634
Gnomad ASJ exome
AF:
0.0137
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000925
Gnomad NFE exome
AF:
0.000519
Gnomad OTH exome
AF:
0.00523
GnomAD4 exome
AF:
0.00378
AC:
5518
AN:
1461236
Hom.:
266
Cov.:
31
AF XY:
0.00335
AC XY:
2439
AN XY:
726982
show subpopulations
African (AFR)
AF:
0.118
AC:
3942
AN:
33454
American (AMR)
AF:
0.00682
AC:
305
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
351
AN:
26118
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39598
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86244
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53362
Middle Eastern (MID)
AF:
0.00975
AC:
56
AN:
5744
European-Non Finnish (NFE)
AF:
0.000291
AC:
323
AN:
1111638
Other (OTH)
AF:
0.00840
AC:
507
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
238
476
714
952
1190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0337
AC:
5129
AN:
152318
Hom.:
286
Cov.:
32
AF XY:
0.0331
AC XY:
2463
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.115
AC:
4788
AN:
41552
American (AMR)
AF:
0.0131
AC:
200
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000529
AC:
36
AN:
68026
Other (OTH)
AF:
0.0198
AC:
42
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
234
467
701
934
1168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0171
Hom.:
82
Bravo
AF:
0.0386
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.00107

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 28, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Warburg micro syndrome 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Martsolf syndrome;C3280214:Warburg micro syndrome 2 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Martsolf syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.9
DANN
Benign
0.69
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2577126; hg19: chr1-220356184; API